Filing Flows › Glaukos (GKOS) › Corneal Health revenue
Glaukos (GKOS) Corneal Health revenue by quarter
Glaukos' Corneal Health revenue was $59.0M in Q3 2026 (third quarter 2026), +94% from Q2 2026. Over the last 7 quarters it ranged from $18.5M (Q1 2025) to $59.0M (Q3 2026).
| Quarter | Corneal Health revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $59.0M | +94% | +154% |
| Q2 2026 | $30.4M | +43% | +48% |
| Q1 2026 | $21.3M | -11% | +15% |
| Q4 2025 | $24.0M | +3% | — |
| Q3 2025 | $23.3M | +13% | — |
| Q2 2025 | $20.6M | +11% | — |
| Q1 2025 | $18.5M | — | — |
Q3 2026 at a glance
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Glaukos' Corneal Health revenue?
Glaukos' Corneal Health revenue was $59.0M in Q3 2026 (third quarter 2026), +94% from Q2 2026.
How has Glaukos' Corneal Health revenue changed?
Over the last 7 quarters it ranged from $18.5M (Q1 2025) to $59.0M (Q3 2026).